COPD

Testing Metformin to Slow Faster Aging in COPD Patients

Updated

Abstract

Metformin may offer potential disease-modifying effects in chronic obstructive pulmonary disease (COPD).

  • COPD is associated with accelerated biological aging and progressive lung function decline.
  • Current therapies for COPD primarily improve symptoms and reduce exacerbations but do not significantly alter disease progression.
  • Metformin has shown anti-aging properties by influencing pathways related to oxidative stress and inflammation.
  • Metformin may modulate mitochondrial dysfunction and cellular aging processes, which are relevant in the context of COPD.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free